Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine
Launched by UNIVERSITY HOSPITAL, GRENOBLE · Nov 4, 2022
Trial Information
Current as of July 06, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial, titled "Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine," is looking into how to better manage chronic inflammatory diseases like rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. The goal is to identify what factors might prevent patients from following the treatment recommendations provided by their doctors. This research is being conducted at the CHU Grenoble Alpes hospital, and they are currently recruiting participants.
To be eligible for this study, participants need to be adults over 18 years old who have been treated for one of the specified conditions and have been hospitalized in the rheumatology department. Both patients and their referring physicians can participate in the study, but certain individuals, such as those with severe psychiatric issues or minors, are excluded. If you join this study, you can expect to help researchers understand better ways to support patients in following their treatment plans, ultimately aiming to improve health outcomes for those living with chronic inflammatory diseases.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patient cohort :
- • men and women over 18 years of age
- • Informed volunteers who have consented to participate in the study
- • have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis
- • have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department
- * Cohort of referring physicians :
- • volunteers who received informed information and consented to participate in the study
- • be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes
- Exclusion Criteria:
- * Patient cohort :
- • psychiatric pathologies or history of behavioural disorders
- • persons referred to in articles L1121-5 to L1121-8 of the Public Health Code
- • persons under guardianship or curatorship
- • not affiliated to the social security system
- • minors
- • Refusal to participate by the patient and/or unreturned questionnaire
- * Cohort of referring physicians:
- • the physician is no longer the patient's referring physician
- • refusal of the doctor to participate and/or questionnaire not returned
About University Hospital, Grenoble
The University Hospital of Grenoble is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent sponsor of clinical trials, the hospital leverages its expertise in various medical disciplines to facilitate cutting-edge studies that aim to improve treatment outcomes and enhance patient safety. With a strong commitment to collaboration, the University Hospital of Grenoble engages in partnerships with academic institutions, industry leaders, and regulatory bodies to drive scientific discovery and translate research findings into clinical practice. Its state-of-the-art facilities and multidisciplinary teams ensure rigorous adherence to ethical standards and regulatory guidelines, fostering an environment where groundbreaking research can thrive.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Grenoble, , France
Grenoble, , France
Grenoble, Grenoble Cedex 9, France
Patients applied
Trial Officials
Xavier ROMAND, PHD
Principal Investigator
CHU Grenoble Alpes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials